AU2001292737A1 - Treating microbial infection of skin lesions - Google Patents

Treating microbial infection of skin lesions

Info

Publication number
AU2001292737A1
AU2001292737A1 AU2001292737A AU9273701A AU2001292737A1 AU 2001292737 A1 AU2001292737 A1 AU 2001292737A1 AU 2001292737 A AU2001292737 A AU 2001292737A AU 9273701 A AU9273701 A AU 9273701A AU 2001292737 A1 AU2001292737 A1 AU 2001292737A1
Authority
AU
Australia
Prior art keywords
microbial infection
skin lesions
treating microbial
treating
lesions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292737A
Inventor
Branson W. Ritchie
Richard E. Wooley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia filed Critical University of Georgia
Publication of AU2001292737A1 publication Critical patent/AU2001292737A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001292737A 2000-09-20 2001-09-19 Treating microbial infection of skin lesions Abandoned AU2001292737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23437500P 2000-09-20 2000-09-20
US60/234,375 2000-09-20
PCT/US2001/029133 WO2002024143A2 (en) 2000-09-20 2001-09-19 Treating microbial infection of skin lesions

Publications (1)

Publication Number Publication Date
AU2001292737A1 true AU2001292737A1 (en) 2002-04-02

Family

ID=22881118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292737A Abandoned AU2001292737A1 (en) 2000-09-20 2001-09-19 Treating microbial infection of skin lesions

Country Status (5)

Country Link
US (1) US20020091074A1 (en)
EP (1) EP1330221B1 (en)
AU (1) AU2001292737A1 (en)
CA (1) CA2423094C (en)
WO (1) WO2002024143A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
AU2003230890A1 (en) * 2002-04-11 2003-10-27 Dvm Pharmaceuticals, Inc. Antimicrobial wash and carrier solutions, and uses thereof
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20140057877A1 (en) * 2002-12-18 2014-02-27 Michael A. Murphy Therapeutic polyamine compositions and their synthesis
BRPI0410505A (en) * 2003-05-07 2006-06-20 Dmi Biosciences Inc oral care methods and products
JP2007500697A (en) * 2003-07-28 2007-01-18 デイビッド・ケイ・アール・カラオリス Method for reducing the toxicity of microbial pathogens and method for inhibiting microbial biofilm formation
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
EP1671623A1 (en) * 2004-10-01 2006-06-21 Giuseppe Vrespa Composition for use in the antibacterial and antiinflammatory treatment of the oral cavity
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US7750201B2 (en) * 2006-04-11 2010-07-06 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
DE102007030931A1 (en) * 2007-07-03 2009-01-08 Birgit Riesinger Composition containing at least one nutritive, at least one disinfecting or decontaminating and / or at least one protease inhibiting active substance and / or active substance complex
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
CA2726529A1 (en) * 2008-05-30 2009-12-23 University Of Cincinnati Use of zinc chelators to inhibit biofilm formation
US20100104614A1 (en) * 2008-06-27 2010-04-29 Oronsky Bryan T Providone compositions for wound healing
WO2010014306A1 (en) * 2008-07-28 2010-02-04 Tyco Healthcare Group Lp Antimicrobial and anticoagulant compositions and methods
EP2318207A4 (en) * 2008-08-28 2012-08-15 Tyco Healthcare Anti-microbial fibers and related articles and methods
WO2010099182A1 (en) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof
US7937772B1 (en) * 2010-01-28 2011-05-10 Lakeland Industries, Inc. Chemical/biological protective garments and laminates
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
US9797073B1 (en) 2011-07-18 2017-10-24 Lakeland Industries, Inc. Process for producing polyvinyl alcohol articles
US9523172B2 (en) 2011-07-18 2016-12-20 Lakeland Industries, Inc. Process for producing polyvinyl alcohol articles
US20150354096A1 (en) 2012-12-20 2015-12-10 Convatec Technologies Inc. Processing of chemically modified cellulosic fibres
WO2014159659A1 (en) 2013-03-12 2014-10-02 Stein Emily A Dental composition comprising chelator and base
US9821063B2 (en) 2013-04-16 2017-11-21 University Of Cincinnati Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators specifically formulated for enhanced inhibition of bacterial colonization and antibacterial efficacy
US10617703B2 (en) * 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
CN105999359B (en) * 2016-06-06 2019-05-21 上海市伤骨科研究所 A kind of external application dressing and its preparation method and application
WO2018081085A1 (en) 2016-10-25 2018-05-03 The Regents Of The University Of California Methods of diagnosis and treatment of alzheimer's disease
RU2649790C1 (en) * 2017-02-22 2018-04-04 Светлана Константиновна Матело Antiseptic composition containing unithiol and dimethylsulfoxide, application of such a composition and method of wound treatment with the use of it
US20200376156A1 (en) * 2019-05-29 2020-12-03 Precision Biologics Methods of accelerating wound healing using cannabinoid compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1539771A (en) * 1976-09-01 1979-02-07 Quinoderm Ltd Dermatological compositions
US4122158A (en) * 1976-09-23 1978-10-24 Alza Corporation Topical therapeutic preparations
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5565189A (en) * 1995-02-03 1996-10-15 Mulder; Gerit D. Wound cleanser method of use
US5624704A (en) * 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6509979B2 (en) * 1997-04-03 2003-01-21 Milliken & Company Printing method using inter-pixel blending on an absorbent substrate
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
WO1999009997A1 (en) * 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
CA2301746C (en) * 1997-08-26 2011-02-15 Board Of Regents, The University Of Texas System Chelators in combination with biocides: treatment of microbially induced biofilm and corrosion
US6423299B1 (en) * 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
AU5087199A (en) * 1998-06-30 2000-01-17 American Medical Research, Inc. Method of treating topical ailments
US6413556B1 (en) * 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
US6270781B1 (en) * 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Also Published As

Publication number Publication date
US20020091074A1 (en) 2002-07-11
WO2002024143A2 (en) 2002-03-28
EP1330221A4 (en) 2007-10-24
CA2423094C (en) 2010-06-22
CA2423094A1 (en) 2002-03-28
EP1330221B1 (en) 2013-05-22
WO2002024143A3 (en) 2002-08-22
EP1330221A2 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
AU2001292737A1 (en) Treating microbial infection of skin lesions
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2001245767A1 (en) Continuous localization and guided treatment of cardiac arrhythmias
AU2001280702A1 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AUPQ877300A0 (en) Topical treatment of skin
AU2001220981A1 (en) Single operator exchange catheters and methods of use
AU2002242904A1 (en) Skin treatment comprising alcohol spirit
AU2001240046A1 (en) Method of treating skin conditions
AU2002231206A1 (en) Treatment of depression
AU3896900A (en) Treatment of pain
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2002319286A1 (en) Skin treatment
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2001245414A1 (en) Treatment of allergies
AU3760900A (en) Treatment of menstrual function
AU2002211561A1 (en) Regulation of human skin healing
AU2001282277A1 (en) Treatment of mycobacterial infection
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU1405001A (en) Treatment of diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU3397301A (en) Treatment of hookworm infection